David J Reynolds

Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.

L. Boone, S. Short, K. Weaver, 2004, Journal of medicinal chemistry.

Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors.

E. Furfine, R. Hazen, David J. Reynolds, 2005, Bioorganic & medicinal chemistry letters.

Preclinical Pharmacology and Pharmacokinetics of GW433908, a Water-Soluble Prodrug of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir

E. Furfine, Dan Todd, Eric S. Furfine, 2004, Antimicrobial Agents and Chemotherapy.

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.

M. Hanlon, E. Furfine, R. Xu, 2006, Bioorganic & medicinal chemistry letters.

Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles.

Michael Brieger, E. Furfine, R. Hazen, 2005, Bioorganic & medicinal chemistry letters.